The ICIS-Pfizer Amanda Proudfoot Tribute Award
is bestowed on an individual whose research on chemokine biology has had an impact on the field early in his/her career. Graduate students and postdoctoral fellows are eligible for this Award. This annual award is presented at the annual ICIS Meeting. This Award is now graciously sponsored by Pfizer!
Amanda Proudfoot is internationally recognized for her important contributions to the field of chemokine biology. Her research focused on the development of anti-inflammatory and anti-infective therapeutic agents and many of the advances in chemokine biology trace back to seminal discoveries made by her. Her group identified and characterized novel chemokines, including CXCL4 and CXCL8, and cloned the chemokine receptors CCR1, CCR2 and CCR4. She provided the first evidence that inhibition of HIV infection of primary macrophages could be achieved through inhibition of CCR5, leading to a new paradigm in the search for HIV inhibitors. Amanda’s research led to the elucidation of several important aspects of the immune system.
Description/Criteria: This ICIS trainee award is dedicated to the memory of Amanda Proudfoot (1949-2019), who is internationally recognized for her important contributions to the field of chemokine biology. This award will be bestowed on an ICIS Student/Postdoc member whose research on chemokine biology has had an impact on the field early in his/her career. Graduate students and postdoctoral fellows are eligible for this Award. This annual award is presented at Cytokines 2024. Funding for this award is provided by friends and colleagues of the late Amanda Proudfoot.
Award: $1,500 and a plaque made possible through the generosity of the friends and colleagues of the late Amanda Proudfoot. The Awardee will be invited for an Oral presentation during the Meeting. This award does not exempt payment of the conference registration fee or include travel expenses.
Submission Guidelines
- An abbreviated CV (max. 3-5 pages) together with a letter of recommendation detailing the accomplishments of the nominee (including confirmation of eligibility) should be uploaded as a combined PDF document.
- No proprietary or confidential information can be included in the application.
- Submission Deadline: 3 April 2024 All the Young Investigator Awards:
Past Amanda Proudfoot Tribute Award Winners for Advances in Chemokine Biology by a Trainee
Announcing the 2021 Amanda Proudfoot Tribute Award Winner for Advances in Chemokine Biology by a Trainee
2020 Inaugural Amanda Proudfoot Tribute Award for Advances in Chemokine Biology by a Trainee
Matteo Massara, PhD
Postdoctoral researcher
Prof. Johanna Joyce’s Lab
University of Lausanne | Ludwig Institute for Cancer Research
AGORA Cancer Center
Lausanne, Switzerland
Matteo Massara received his Master’s degree in Veterinary Biotechnologies with honors in 2014 at the University of Milan. He started his scientific training at the Experimental Immunopathology Lab supervised by Prof. Cecilia Garlanda studying the role of the negative regulator of inflammation IL-1R8/TIR8 in lymphoma and breast cancer development. Then, he got in 2018 the Ph.D. in Experimental Medicine and Medical Biotechnologies at the University of Milan attending the Laboratory of Leukocytes Biology at Humanitas Clinical and Research Center (Italy) under the supervision of Prof. Raffaella Bonecchi and Prof. Massimo Locati. As PhD student, Dr. Massara contributes to characterize the role of the atypical chemokine receptor ACKR2/D6 in lung metastasis. Dr. Massara is currently a postdoctoral researcher at the Tumor Microenvironment Lab leaded by Prof. Johanna Joyce at University of Lausanne (Switzerland). His scientific activity is focused on fundamental mechanisms of leukocyte recruitment, activation and communication in brain metastasis.
https://twitter.com/massara_matteo
Dr. Massara will give a virtual oral presentation at Cytokines 2020 Virtual Meeting in November!
